Joanna Gale

4PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.

Simon J Crabb, Syed Hussain, Eileen Soulis

|Nov 10, 2021
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.

Hannah L Rush, Laura Murphy, Alicia K Morgans

Pageof 1